G Drobinski - Concepedia

Author

G Drobinski

Also Known As

B Bourbigot, G Drobinski, G. DROBINSKI, G. Drobinski, G.érard Drobinski, Gerard Drobinski, Gérard Drobinski, GÉRARD DROBINSKI, Gérard Drobinski

185

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Pitié-Salpêtrière Hospital Sorbonne Université Société Française de Cardiologie Inserm Hôpital Necker-Enfants Malades

About

G Drobinski is an author at Pitié-Salpêtrière Hospital specializing in cardiovascular disease, medicine, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	25	2.6K
2	Public Health	11	11	2K
3	Health Sciences	3	3	71
4	Anesthesia	1	1	18
5	Cardiothoracic Surgery	1	1	10

G Drobinski

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Prevalence of Patent Foramen Ovale in Patients with Stroke P Lechat, Jean‐Louis Mas, G Lascault, New England Journal of Medicine Cerebrovascular DiseaseNeurovascular DiseaseThrombosisVenous ThrombosisStroke	1988	1.7K
Myocardial viability in patients with Q wave myocardial infarction and no residual ischemia. Gilles Montalescot, Marc Faraggi, G Drobinski, Circulation	1992	276
Percutaneous Coronary Intervention After Subcutaneous Enoxaparin Pretreatment in Patients With Unstable Angina Pectoris J.‐P. Collet, Gilles Montalescot, Linda Lison, Circulation	2001	219
Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina Gilles Montalescot, Jean‐Philippe Collet, Linda Lison, Journal of the American College of Cardiology ThrombosisCardiovascular DiseaseUnstable AnginaVarious Anticoagulant TreatmentsPharmacology	2000	132
Fibrinogen After Coronary Angioplasty as a Risk Factor for Restenosis Gilles Montalescot, Annick Ankri, Éric Vicaut, Circulation	1995	122
A unique, low dose of intravenous enoxaparin in elective percutaneous coronary intervention R. Choussat, Gilles Montalescot, Jean‐Philippe Collet, Journal of the American College of Cardiology ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseLow DoseMedicine	2002	122
Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease Gilles Montalescot, Annick Ankri, Bernadette Chadefaux-Vekemans, International Journal of Cardiology Plasma HomocysteineMetabolic SyndromeVascular DiseaseCardiovascular DiseaseHyperlipidemia	1997	79
Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure Gilles Montalescot, G Drobinski, Philippe Meurin, The American Journal of Cardiology HypertensionHeart FailurePulmonary Vascular TonePulmonary Arterial HypertensionCardiovascular Disease	1998	77
Effects of Abciximab on the Architecture of Platelet-Rich Clots in Patients With Acute Myocardial Infarction Undergoing Primary Coronary Intervention J.‐P. Collet, G Montalescot, Claude Lesty, Circulation	2001	75
Eptifibatide provides additional platelet inhibition in Non–ST-Elevation myocardial infarction patients already treated with aspirin and clopidogrel Miles Dalby, Gilles Montalescot, Claire Bal dit Sollier, Journal of the American College of Cardiology ThrombosisCardiovascular DiseaseBlood PlateletMedicinePharmacotherapy	2004	62

Page 1